News About: Pharm. Industry
Binex to sign KITEC over commissioned management of KBCC in October
Korea Institute of Industrial Technology (KITEC) will sign an agreement with Binex Co., Ltd. on October to commission the overall management of the Korea Biotechnology Commercialization Center (KBCC) for the next 10 y...
US FDA approves Korean EPO drug
Hanmi Pharm said on September 17 it has received approval from the U.S. Food and Drug Administration to conduct Phase I clinical trial of a new erythropoietin (EPO) for the treatment of anemia.
The company said the...
Wooridul Life Sciences to be split into two in December
Wooridul Life Sciences Ltd. will be split into two – Wooridul Pharm and Wooridul Life Sciences – in December.
Shareholders will get 58 shares of Wooridul Pharm in exchange for 100 Wooridul shares, and 42 shares of ...
Approval procedures for 4 new vaccines under way
Four local pharmaceutical companies have embarked on the approval application of their new swine vaccines, health officials said on September 18.
Boryung Pharm and Hanwha Pharm are seeking to receive their green li...
Choong-wae wins US patent for Wnt target anticancer agent
Choong-wae Pharm said on September 18 it recently won the U.S. substance patent for the building-block molecules of Wnt target anticancer drug (code name: CWP231A).
“We have a plan to explore overseas markets for w...
Flu fear boosts vitamin C sales
Sales of Lemona C, a locally popular vitamin C brand, have surged for the recent three months due to growing concerns over the rapidly spreading H1N1 flu virus, according to Kyungnam Pharm.
“The grow rate of Lemon...
Dongsung to release buccal insulin product in 2011
Dongsung Pharm plan to introduce oral insulin (Oral-lyn) for the treatment of subjects with Type-1 and Type-2 diabetes in January 2011.
In August 2008, Dongsung obtained exclusive right to market Oral-lyn in Korea ...
71 side effects reported in swine flu shot
There have been a total of 71 minor adverse events from the first set of injections of the new vaccine (GC1115), the Korea Food and Drug Administration said on September 18.
Because the side effects in adults (e.g....
Clevudine to be released in the Philippines
Bukwang Pharm said on September 17 that its homegrown medicine clevudine (generic name) will be launched in the Philippines by HI-Eisai Pharmaceutical Inc. a subsidiary in the Philippines of Eisai Co., Ltd.
The Bur...
Flu marketing for hand sanitizers is losing momentum
Despite the warnings by health authorities against influenza A (H1N1) related advertising, a growing number of Korean pharmaceutical firms are racing to exploit fears for quick revenue, and have been stocking stores w...
